首页> 外文OA文献 >Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes
【2h】

Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes

机译:大肠癌风险对DNA错配修复基因突变的母源的依赖性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genetic diseases associated with dynamic mutations in microsatellite DNA often display parent-of-origin effects (POEs) in which the risk of disease depends on the sex of the parent from whom the disease allele was inherited. Carriers of germline mutations in mismatch repair (MMR) genes have high risks of colorectal carcinoma (CRC). We investigated whether these risks depend on the parent-of-origin of the mutation. We studied 422 subjects, including 89 MMR gene mutation carriers, from 17 population-based families who were each recruited via a CRC case diagnosed before age 45 years and found to carry a MMR gene mutation. The POE hazard ratio (HRPOE), defined to be the CRC incidence for carriers with maternally derived mutations divided by the corresponding paternal incidence, was estimated using a novel application of modified segregation analysis. HRPOE (95% confidence interval) was estimated to be 3.2 (1.1–9.8) for males (P = 0.03) and 0.8 (0.2–2.8) for females (P = 0.5) and the corresponding cumulative risks to age 80 years were 88% (54%–100%) for male carriers with maternally derived mutations and 38–48% for all other carriers. If confirmed by larger studies, these results will have important implications for the etiology of CRC and for the clinical management of MMR gene mutation carriers.
机译:与微卫星DNA的动态突变相关的遗传疾病通常表现出“原产地效应”(POE),其中疾病的风险取决于遗传疾病等位基因的父母的性别。错配修复(MMR)基因中的种系突变携带者具有大肠癌(CRC)的高风险。我们调查了这些风险是否取决于突变的起源。我们研究了来自17个基于人口的家庭的422名受试者,其中包括89位MMR基因突变携带者,这些受试者都是通过在45岁之前被诊断出并携带MMR基因突变的CRC病例招募的。 POE危险比(HRPOE)被定义为具有母本衍生突变的携带者的CRC发生率除以相应的父本发生率,这是使用改良的分离分析的新应用估算得出的。男性(P = 0.03)的HRPOE(95%置信区间)估计为3.2(1.1-9.8),女性(P = 0.5)为0.8(0.2-2.8),相应的80岁年龄累积风险为88% (54%–100%)对于具有母源突变的男性携带者,所有其他携带者为38–48%。如果得到较大研究的证实,这些结果将对CRC的病因学以及MMR基因突变携带者的临床管理产生重要影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号